Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Parkinson Disease D010300 53 associated lipids
von Willebrand Diseases D014842 2 associated lipids
Ascorbic Acid Deficiency D001206 9 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Atherosclerosis D050197 85 associated lipids
Insulin Resistance D007333 99 associated lipids
Dehydration D003681 11 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Critical Illness D016638 13 associated lipids
Anemia, Iron-Deficiency D018798 6 associated lipids
Myocardial Stunning D017682 10 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Carcinogenesis D063646 3 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Restless Legs Syndrome D012148 2 associated lipids
Iron Overload D019190 11 associated lipids
Anemia, Refractory D000753 3 associated lipids
Calcium Metabolism Disorders D002128 1 associated lipids
Anemia, Neonatal D000751 1 associated lipids
Gilbert Disease D005878 2 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Raman S et al. Evolution-guided optimization of biosynthetic pathways. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:25453111
Tiwari P et al. Combinatorial chemopreventive effect of butyric acid, nicotinamide and calcium glucarate against the 7,12-dimethylbenz(a)anthracene induced mouse skin tumorigenesis attained by enhancing the induction of intrinsic apoptotic events. 2015 Chem. Biol. Interact. pmid:25478867
pmid:25514744
pmid:25514745
Almilaji A et al. Regulation of the voltage gated K channel Kv1.3 by recombinant human klotho protein. 2014 Kidney Blood Press. Res. pmid:25571875
pmid:25609135
Franco G Occupational exposure to anaesthetics: liver injury, microsomal enzyme induction and preventive aspects. 1989 G Ital Med Lav pmid:2562737
Frezza M et al. Abnormal serum gamma-glutamyltranspeptidase in alcoholics. Clues to its explanation. 1989 Neth J Med pmid:2563572
Toblli JE et al. Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron. 2015 Heart Lung Circ pmid:25666998
pmid:25698609
Freche JP et al. [Variation in the urinary excretion of 6-beta-hydroxycortisol in humans after administration of the new isoquinoline derivative, PK-11195 (52028 RP)]. 1989 Sep-Oct Therapie pmid:2573163
pmid:25754747
Coddington KA et al. Enterohepatic circulation of T-2 toxin metabolites in the rat. 1989 Nov-Dec Drug Metab. Dispos. pmid:2575494
Dai P et al. Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids. 2015 AAPS J pmid:25762448
Pasquini R et al. Thioethers, mutagens, and D-glucaric acid in urine of operating room personnel exposed to anesthetics. 1989 Teratog., Carcinog. Mutagen. pmid:2576815
pmid:25802012
pmid:25824489
Toblli JE et al. Cardiovascular outcomes of intravenous iron in perspective of clinical trials and the use of different iron preparations. 2015 Int. J. Cardiol. pmid:25838213
pmid:25890861
pmid:25906050
Kitasato I et al. Effect of glucarolactam on low-dose nephrotoxicities of dibekacin and gentamicin in Fischer rats. 1989 Drugs Exp Clin Res pmid:2591297
Yokota M et al. Effect of glucarolactam on ototoxicity of aminoglycoside antibiotics in guinea-pigs. 1989 Drugs Exp Clin Res pmid:2591298
Bhandari S et al. A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients. 2015 Nephrol. Dial. Transplant. pmid:25925701
Horváth T et al. Drug metabolism in drug-induced liver diseases: pathogenetic role of active metabolites. 1989 Acta Physiol Hung pmid:2596319
Connor JR et al. Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations. 2015 PLoS ONE pmid:25973894
pmid:26031262
Agarwal R et al. A randomized trial of intravenous and oral iron in chronic kidney disease. 2015 Kidney Int. pmid:26083656
pmid:26118386
pmid:26149838
pmid:26168105
Ren X et al. Effect of Intravenous Iron Supplementation on Acute Mountain Sickness: A Preliminary Randomized Controlled Study. 2015 Med. Sci. Monit. pmid:26175087
Minami D et al. Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model. 2015 Cancer Sci. pmid:26211743
Airy M et al. Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. 2015 Nephrol. Dial. Transplant. pmid:26311216
pmid:26385819
pmid:26422625
pmid:26526024
pmid:26575062
pmid:26605680
pmid:26637994
Mori M et al. Urinary and biliary metabolites of mephentermine in male Wistar rats. 1989 Xenobiotica pmid:2665325
Tiwari P et al. Preventive effects of butyric acid, nicotinamide, calcium glucarate alone or in combination during the 7, 12-dimethylbenz (a) anthracene induced mouse skin tumorigenesis via modulation of K-Ras-PI3K-AKTpathway and associated micro RNAs. 2016 Biochimie pmid:26655363
pmid:26657161
Bitsi S et al. Profound hyperglycemia in knockout mutant mice identifies novel function for POU4F2/Brn-3b in regulating metabolic processes. 2016 Am. J. Physiol. Endocrinol. Metab. pmid:26670484
pmid:26686338
pmid:26749401
pmid:26796581
Lee T et al. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. 2017 Gut pmid:26848182
pmid:26868063
pmid:26901550
pmid:26934422